Exchange: NASDAQ·Updated 07:30 PM EDT
ORMP logo

ORMP Oramed Pharmaceuticals, Inc

$5.02
$0.08
(1.62%)
Today
Closed $5.01
$0.01
(0.20%)
After Hours
EarningsNov 12
Mkt Cap$205.07M
Vol226,874.00

About ORMP

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.
44

Bearish Sentiment

How do you feel about ORMP?

Advertisement|Remove ads.